secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-002939
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics files investor presentation with no material updates disclosed
--------------------------------------------------------------------------------

- Filed an investor presentation under Item 7.01 for Regulation FD purposes.
- Presentation slide titled 'Targeting Pathogenic Oligomers: A Disruptive Approach to Neurodegenerative Diseases'.
- No financial results, pipeline milestones, or guidance changes are included in the filing.
- Filing is a routine disclosure; no new material events reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/0001104659-25-002939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/tm253137d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer